Clinical Trials Browser

Recruiting × NETWORK × Hodgkin Disease × Clear all

Anemia, Aplastic, Autoimmune Diseases, Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05180097 2026-02-02

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Recruiting

84 enrolled

Lymphoid

Hodgkin Disease

NCT07209059 2025-10-06

FINISH-HL

Phase 2 Recruiting

30 enrolled

Lymphoid

Hodgkin Disease

NCT04726501 2025-02-13

CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

Phase 4 Recruiting

200 enrolled

Lymphoid

Hodgkin Disease

NCT06263530 2024-02-16

Prognostic Significance of ctDNA in HL

Recruiting

500 enrolled

Lymphoid

Hodgkin Disease

Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

FINISH-HL

CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

Prognostic Significance of ctDNA in HL